Factors predicting relapse in elderly patients with major depressive disorder treated with escitalopram in an outpatient setting

Current Medical Research and Opinion

Volumn 30, Issue 7, 2014, Pages 1301-1307

  Dolberg, Ornah ^a   Larsson Lönn, Sara ^a   Kvist, Kajsa ^a  

^a H LUNDBECK A S   (Denmark)

Author keywords

Elderly; Escitalopram; HSQ 12; Major depressive disorder; Predictive factors; Relapse

Indexed keywords

ESCITALOPRAM; PLACEBO; ANTIDEPRESSANT AGENT; CITALOPRAM;

ADULT; AGED; AGING; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; OUTCOME ASSESSMENT; OUTPATIENT; PREDICTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RELAPSE; REMISSION; TREATMENT DURATION; AMBULATORY CARE; DEPRESSIVE DISORDER, MAJOR; DOSE RESPONSE; DRUG ADMINISTRATION; RECURRENT DISEASE; TREATMENT OUTCOME; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; CITALOPRAM; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; HUMANS; MALE; QUALITY OF LIFE; RECURRENCE; TREATMENT OUTCOME;

EID: 84903608311     PISSN: 03007995     EISSN: 14734877     Source Type: Journal    
DOI: 10.1185/03007995.2014.904770     Document Type: Article

References (15)

1. Sá; nchez C, Bøgesø KP, Ebert B, et al. Escitalopram versus citalopram: Uhe surprising role of the R-enantiomer. Psychopharmacology 2004;174:163-76
2. Kasper S, Lemming OM, de Swart H. Escitalopram in the long-Term treatment of major depressive disorder in elderly patients. Neuropsychobiology 2006;54:152-9
3. Mohamed S, Osatuke K, Aslam M, et al. Escitalopram for comorbid depression and anxiety in elderly patients: A 12-week, open-label, flexible-dose, pilot trial. Am J Geriatr Pharmacother 2006;4:201-9 (Pubitemid 44575959
4. Möller HJ, Schnitker J, Flürenbrock W. Factors associated with response in depressed elderly outpatients treated with escitalopram in a naturalistic setting in Germany. Pharmacopsychiatry 2010;43:210-15
5. Nelson JC, Delucchi K, Schneider LS. 2008. Efficacy of second generation antidepressants in late-life depression: A meta-Analysis of the evidence. Am J Geriatr Psychiatry 16:558-67
6. Kasper S, de Swart H, Andersen HF. Escitalopram in the treatment of depressed elderly patients. Am J Geriatric Psychiatry 2005;13:884-91 (Pubitemid 46638677
7. Bose A, Li D, Gandhi C. Escitalopram in the acute treatment of depressed patients aged 60 years or older. Am J Geriatr Psychiatry 2008;16:14-20
8. Gorwood P, Weiller E, Lemming O, et al. Escitalopram prevents relapse in older patients with major depressive disorder. Am J Geriatr Psychiatry 2007;15:581-93
9. ICH. 1996 ICH Harmonised Tripartite Guideline E6: Guideline for Good Clinical Practice. Available at: Www.ich.org/pdfICH/e6.pdf. Last accessed 6 March 2014
10. World Medical Association (WMA). Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects. 2000. Available at: Http:// www.wma.net/en/30publications/10policies/b3/. Last accessed 6 March 2014
11. Lecrubier Y, Sheehan DV, Weiller E, et al. The Mini International Neuropsychiatric Interview (MINI). A short diagnostic structured interview: Reliability and validity according to the CIDI. Eur Psychiatry 1997;12:224-31
12. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, fourth edition text revision. Washington, DC: American Psychiatric Association, 2000
13. Guy W. ECDEU Assessment Manual for Psychopharmacology (rev., 1976) Biometric Laboratory. US Dept. of Health, Education, and Welfare-DHEW Publication No. (ADM) 218-222. Kensington, Maryland: Uhe George Washington University, 1976
14. Pettit T, Livingston G, Manela M, et al. Validation and normative data of health status measures in older people: Uhe Islington study. Int J Geriatr Psychiatry 2001;16:1061-70 (Pubitemid 33089270
15. Lyketsos CG, Weiller E, Katona K, et al. Are old-old patients with major depression more likely to relapse than young-old patients during continuation treatment with escitalopram? BMC Geriatrics 2011;11:2.